Cambridge Cognition Expands Partnership With Actinogen

Reuters
16 Jan
Jan 16 (Reuters) - Cambridge Cognition Holdings PLC ::
*EXPANDED PARTNERSHIP WITH ACTINOGEN
*EXPANDS PARTNERSHIP WITH ACTINOGEN FOR PHASE 2B/3 XANAMIA ALZHEIMER'S DISEASE TRIAL

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 16-JAN-202507:00:05 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10